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Summary: Mapping the chromo-
somal locations of transcription fac-
tors, nucleosomes, histone modifica-
tions, chromatin remodeling
enzymes, chaperones, and polymer-
ases is one of the key tasks of
modern biology, as evidenced by
the Encyclopedia of DNA Elements
(ENCODE) Project. To this end, chro-
matin immunoprecipitation followed
by high-throughput sequencing
(ChIP-seq) is the standard methodo-
logy. Mapping such protein-DNA
interactions in vivo using ChIP-seq
presents multiple challenges not
only in sample preparation and
sequencing but also for computa-
tional analysis. Here, we present
step-by-step guidelines for the com-
putational analysis of ChIP-seq data.
We address all the major steps in the
analysis of ChIP-seq data: sequencing
depth selection, quality checking,
mapping, data normalization, assess-
ment of reproducibility, peak calling,
differential binding analysis, control-
ling the false discovery rate, peak
annotation, visualization, and motif
analysis. At each step in our guide-
lines we discuss some of the software
tools most frequently used. We also
highlight the challenges and pro-
blems associated with each step in
ChIP-seq data analysis. We present
a concise workflow for the analysis of
ChIP-seq data in Figure 1 that
complements and expands on the
recommendations of the ENCODE
and modENCODE projects. Each step
in the workflow is described in detail
in the following sections.
Introduction to ChIP-seq
Technology
Chromatin immunoprecipitation followed
by sequencing (ChIP-seq), first described in
2007 [1–4], allows in vivo determination of
where a protein binds the genome, which
can be transcription factors, DNA-binding
enzymes, histones, chaperones, or nucleo-
somes. ChIP-seq first cross-links bound
proteins to chromatin, fragments the
chromatin, captures the DNA fragments
bound to one protein using an antibody
specific to it, and sequences the ends of the
captured fragments using next-generation
sequencing (NGS). Computational map-
ping of the sequenced DNA identifies the
genomic locations of bound DNA-binding
enzymes, modified histones, chaperones,
nucleosomes, and transcription factors
(TFs), thereby illuminating the role of these
protein-DNA interactions in gene expres-
sion and other cellular processes. The use
of NGS provides relatively high resolution,
low noise, and high genomic coverage
compared with ChIP-chip assays (ChIP
followed by microarray hybridization).
ChIP-seq is now the most widely used
procedure for genome-wide assays of
protein-DNA interaction [5], and its use
in mapping histone modifications has been
seminal in epigenetics research [6].
The Analysis of ChIP-seq Data
Sequencing Depth
Effective analysis of ChIP-seq data
requires sufficient coverage by sequence
reads (sequencing depth). The required
depth depends mainly on the size of the
genome and the number and size of the
binding sites of the protein. For mamma-
lian transcription factors (TFs) and chromatin
modifications such as enhancer-associated
histone marks, which are typically localized
at specific, narrow sites and have on the
order of thousands of binding sites, 20
million reads may be adequate (4 million
reads for worm and fly TFs) [7]. Proteins
with more binding sites (e.g., RNA Pol II)
or broader factors, including most histone
marks, will require more reads, up to 60
million for mammalian ChIP-seq [8].
Importantly, control samples should be
sequenced significantly deeper than the
ChIP ones in a TF experiment and in
experiments involving diffused broad-do-
main chromatin data. This is to ensure
sufficient coverage of a substantial portion
of the genome and non-repetitive autoso-
mal DNA regions. To ensure that the
chosen sequencing depth was adequate, a
saturation analysis is recommended—the
peaks called should be consistent when the
next two steps (read mapping and peak
calling) are performed on increasing num-
bers of reads chosen at random from the
actual reads. Saturation analysis is built
into some peak callers (e.g., SPP [9]). If this
shows that the number of reads is not
adequate, reads from technical replicate
experiments can be combined. To avoid
over-sequencing and estimate an optimal
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sequencing depth, it is important to take
into account library complexity. Several
tools are available for this purpose. For
example, the preseq package allows users
to predict the number of redundant reads
from a given sequencing depth and how
many will be expected from additional
sequencing [10]. Similarly, the ENCODE
software tools offer a quality metric called
the PCR bottleneck coefficient (PBC),
defined as the fraction of genomic locations
with exactly one unique read versus those
covered by at least one unique read.
Read Mapping and Quality Metrics
Before mapping the reads to the
reference genome, they should be filtered
by applying a quality cutoff (Box 1). The
remaining reads should then be mapped
using one of the available mappers such as
Bowtie [11], BWA [12], SOAP [13], or
MAQ [14]. Recent versions support
gapped alignment (e.g., Bowtie2), but
detection of indels is not necessary for
most ChIP-seq experiments. It is impor-
tant to consider the percentage of uniquely
mapped reads reported by the mapper.
The percentage varies between organisms,
and for human, mouse, or Arabidopsis
ChIP-seq data, above 70% uniquely mapped
reads is normal, whereas less than 50%
may be cause for concern. A low percent-
age of uniquely mapped reads often is due
either to excessive amplification in the PCR
step, inadequate read length, or problems
with the sequencing platform, but with
some ChIPed proteins it may be unavoid-
able (e.g., if the protein binds frequently in
repetitive DNA). The read mappers are
designed to allow a (user-settable) number
of mismatches in the reads, and it is
important to choose this parameter to be
appropriate with the NGS platform being
used (consult the manufacturer). A final
potential cause of high numbers of ‘‘multi-
mapping’’ reads is that the protein binds
frequently in regions of repeated DNA. In
this last case, using paired-end sequencing to
reduce the mapping ambiguity may help. It
should be kept in mind that multi-mapping
reads will be ignored (filtered out) by most
peak-calling algorithms (see section ‘‘Peak
Calling’’), although they can drive the
discovery of novel binding sites [15].
After mapping, the signal-to-noise ratio
(SNR) of the ChIP-seq experiment should
be assessed, for example via quality metrics
such as strand cross-correlation [7] or IP
enrichment estimation using the software
package CHANCE [16] (Box 2). These
measures will detect several possible failure
modes of ChIP-seq: insufficient enrichment
by immunoprecipitation step, poor frag-
ment-size selection, or insufficient sequenc-
ing depth. Strand cross-correlation analysis
is built into some peak callers (e.g., SPP or
MACS [17] [version 2]).
Peak Calling
A pivotal analysis for ChIP-seq is to
predict the regions of the genome where
the ChIPed protein is bound by finding
regions with significant numbers of
mapped reads (peaks). A fine balance
between sensitivity and specificity depends
on choosing an appropriate peak-calling
algorithm and normalization method
(Boxes 3–6, Table S1, and [18,19])
based on the type of protein ChIPed:
point-source factors such as most TFs
(Box 3), broadly enriched factors such as
histone marks (Box 4), and those with
both characteristics such as RNA Pol II
(Box 5) [20]. It is strongly recommended
that mapped reads from a control sample
be used (e.g., from input DNA), although
some peak callers can use GC content or
mappability as information necessary to
assess the level of non-specific or back-
ground binding. Duplicate reads (same 59
end) can be removed before peak calling to
improve specificity (Box 7). Although
some peak callers support both single
and paired-end reads (e.g., MACS), others
Figure 1. Workflow for the computation-
al analysis of ChIP-seq.
doi:10.1371/journal.pcbi.1003326.g001
Box 1. Quality metrics of sequence reads
Preprocessing of ChIP-seq data will, in general, be similar to that of any other
sequencing data and will assess the quality of the raw reads to identify possible
sequencing errors or biases (FastQC can be used for an overview of the data
quality). Phred quality scores are used to describe the confidence of each base call
in each sequence tag, are logarithmically linked to error probabilities, and can be
used to filter low-quality reads. After this filtering step, it may also be necessary to
trim the end of reads that are of low quality (see sickle, https://github.com/
najoshi/sickle). Additionally, library complexity is a common quality measure for
ChIP-seq libraries (preseq package [10] or PCR bottleneck coefficient [PBC] from
ENCODE tools, https://code.google.com/p/phantompeakqualtools/), and library
complexity is linked to many factors such as antibody quality, over-cross-linking,
amount of material, sonication, or over-amplification by PCR. The latter can be
corrected by systematic identification and removal of redundant reads, which is
implemented in many peak callers as it may improve their specificity. Readers
may be interested in the Galaxy toolbox, which offers access to many of the tools
described here [50].
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are specifically designed to improve sensitivity
and specificity in paired-end sequencing
(e.g., SIPeS [21]). Existing peak callers
have many user-settable parameters that
can greatly affect the number and quality
of the peaks called. For instance, the
enrichment metric for most peak callers,
such as p-value or FDR, could be hugely
affected by the statistical model used, the
sequencing depth, or the actual number of
binding sites in the genome. Thus, using
the same p-value or FDR threshold does
not ensure that the numbers of peaks called
are comparable across libraries and diffe-
rent peak callers [22]. A better approach is
to threshold the irreproducible discovery
rate (IDR) [23], which, along with motif
analysis, can also aid in choosing the best
peak-calling algorithm and parameter set-
tings (see sections ‘‘Assessment of Repro-
ducibility’’ and ‘‘Motif Analysis’’).
Assessment of Reproducibility
To ensure that experimental results are
reproducible, it is recommended to per-
form at least two biological replicates of
each ChIP-seq experiment and examine
the reproducibility of both the reads and
identified peaks [7,24]. The reproducibil-
ity of the reads can be measured by
computing the Pearson correlation coeffi-
cient (PCC) of the (mapped) read counts at
each genomic position [25]. The range of
PCC is typically from 0.3–0.4 (for unre-
lated samples) to .0.9 (for replicate
samples in high-quality experiments).
Low values typically suggest one or both
replicates may be of low quality. However,
this quantity can be dominated by a small
number of very highly enriched regions, so
it may not reflect the reproducibility for
regions that are less enriched [26]. Thus it
is important to remove the artefact regions
with high ChIP signals, such as regions
near centromeres, telomeres, satellite re-
peats, and ENCODE and 1000 Genomes
blacklisted regions, before computing the
PCC. To measure the reproducibility at
the level of peak calling, IDR analysis
(Box 8) [23] can be applied to the two sets
of peaks identified from a pair of repli-
cates. This analysis assesses the rank
consistency of identified peaks between
replicates, and outputs the number of
peaks that pass a user-specified reproduc-
ibility threshold (e.g., IDR = 0.05). It has
been reported that using a reproducibility-
based metric (e.g., IDR) rather than an
enrichment-based metric (e.g., FDR or p-
value) makes the numbers of peaks
declared more comparable across experi-
ments [7]. In addition, IDR analysis can
also be used for comparing and selecting
peak callers [8,23] and identifying exper-
iments with low quality [7].
Differential Binding Analysis
Comparative ChIP-seq analysis of an
increasing number of protein-bound re-
gions across conditions or tissues is ex-
pected with the steady raise of NGS
projects. For example, temporal or devel-
opmental designs of ChIP-seq experiments
can provide different snapshots of a
binding signal for the same TF, uncover-
ing stage-specific patterns of gene regula-
tion [27,28]. With this in mind, one should
note that the simple binary overlap of two
sets of peaks (e.g., BEDTools [29]) does
not represent the optimal approach when
comparing peaks [25].
Two alternatives have been proposed.
The first one—qualitative—implements
hypothesis testing on multiple overlapping
sets of peaks [30], therefore extending the
two-set overlap approach mentioned
above. The second one—quantitative—
proposes the analysis of differential bind-
ing between conditions based on the total
counts of reads in peak regions or on the
read densities, i.e., counts of reads over-
lapping at individual genomic positions
(Table S3 and [31,32]). The direct
calculation of differentially bound regions
Box 2. Quality metrics of read counts
Strand cross-correlation analysis [7] assesses data quality by measuring the
degree of immunoprecipitated (IP) fragment clustering in ChIP-seq experiments.
It is developed based on the observations that (1) a high-quality ChIP-seq
experiment often shows a significant clustering of enriched DNA sequence tags at
the locations bound by the protein of interest, and that (2) the enriched sequence
tags on the forward and reversed strands are positioned at a distance from the
binding site center that depends on the fragment size distribution [9]. This
method quantifies the degree of clustering by computing the cross-correlation
between the two strands, i.e., the Pearson correlation between the strand-specific
read density profiles as a function of the shift (k) applied to one of the two strands
(Figure S1). The cross-correlation typically peaks at the shift corresponding to
the fragment length and the shift corresponding to the read length. The ratio
between the cross-correlation at the fragment length and the background cross-
correlation, referred to as normalized strand cross-correlation coefficient (NSC),
and the ratio between cross-correlation at the fragment length and the cross-
correlation at the read length, referred to as relative strand cross-correlation
coefficient (RSC), jointly reflect signal-to-noise ratio in the ChIP-seq data. Very
successful ChIP experiments generally have NSC.1.05 and RSC.0.8 [7], although
there can still be significant biological information present in ChIP-seq data not
meeting these criteria. Readers may refer to [7] for prototypical profiles of cross-
correlation illustrated on ENCODE data.
The software CHANCE [16] assesses IP strength by estimating and comparing the
IP reads pulled down by the antibody and the background, using a method called
signal extraction scaling [77]. For each sample, it first bins the genome into non-
overlap bins both for the IP and the Input, then partitions the bins into a signal
region and a background region by comparing the cumulative distributions of
tag counts in the bins of the IP and the Input. It next computes a p-value for
significance of enrichment according to the percentage allocation of reads in
each type of regions. Based on the empirical p-value distribution computed from
a set of ENCODE IP-Input and Input-input experiments on human data, it
estimates a q-value by treating the two types of experiments as true positives and
false positives, respectively. The q-value thus is interpreted as the fraction of
comparisons with ENCODE data that show differential enrichment at the level of
the user’s data but turn out to be technical replicates of the Inputs. The software
determines the success of the experiment based on the q-values, and also reports
some descriptive quality statistics, such as the percentage increase in mean tag
density in IP compared to Input and the percentage of the genome classified as
signal region. Because the q-values are computed based on human data, users
should be aware that the q-values may not be relevant if their data are generated
from other organisms.
CHANCE also provides a graphical visualization of IP strength with genome
coverage, by plotting the empirical cumulative percentage of tags covered by the
bins that are sorted in an increasing order of read density for both the IP and the
Input. By examining and comparing the IP and Input curves, one may identify
quality issues, such as insufficient sequencing depth, amplification bias, and weak
IP enrichment.
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between treatment samples without con-
trols (i.e., using one of them as a control) is
not recommended because highly enriched
regions could be identified due to artefacts
or different chromatin structure and not
due to true binding events.
Typically, both methodologies assume
that significant (see section ‘‘Peak Calling’’)
and reproducible (see section ‘‘Assessment
of Reproducibility’’) peaks have been found
in advance independently for each condi-
tion. In order to increase sensitivity for
detecting differentially bound regions (at
the expense of increasing the number of
false positives), more relaxed thresholds can
be used to find peaks at each condition.
Then, depending on the biological ques-
tion, the sets of peaks called in any of the
conditions can be considered separately, or
collapsed into one or more meaningful lists
of consensus peak regions. One can use the
qualitative approach to get an initial over-
view of differential binding. However, peaks
identified in all conditions will never be
declared as differentially bound sites by this
approach based just on the positions of the
peaks [33]. The quantitative approach works
with read counts (e.g., DBChIP [33]) or
read densities (e.g., MAnorm [34]) com-
puted over peak regions, and has higher
computational cost, but is recommended as
it provides precise statistical assessment of
differential binding across conditions (e.g.,
p-values or q-values linked to read-enrich-
ment fold changes). It is strongly advised
to verify that the data fulfill the require-
ments of the software chosen for the
analysis. For instance, DIME [35] assumes
that a significant proportion of peaks are
common to the conditions under compar-
ison, MAnorm assumes that peaks that are
common in both conditions do not change
significantly, while other methodologies
may expect a constant number of peaks
across conditions [25]. Importantly, with
some tools only two conditions can be
submitted simultaneously for comparison
(e.g., MAnorm), and some may perform
better depending on the protein ChIPed
(e.g., ChIPDiff [36] for histone marks and
POLYPHEMUS [37] for RNA Pol II).
Peak Annotation
The aim of the annotation is to associate
the ChIP-seq peaks with functionally
relevant genomic regions, such as gene
promoters, transcription start sites, inter-
genic regions, etc. In the first step, one
uploads the peaks and reads (in an
appropriate format, e.g., BED or GFF
for peaks, WIG or bedGraph for normal-
ized read coverage; see Text S1 and [38–
41]) to a genome browser, where regions
can be manually examined in search for
associations with annotated genomic fea-
tures. If comparable data (e.g., ChIP-
qPCR) is available, it can be compared
with the ChIP-seq peaks and reads
manually in the browser as well. A
systematic analysis can also be performed
using tools in packages such as BEDTools
to compute the distance from each peak to
the nearest landmark (e.g., TSS), or to
identify the genes within a given distance
of a peak. The output of such ‘‘location
analyses,’’ obtained for instance using
CEAS [42] or the Bioconductor package
ChIPpeakAnno [43], can be further cor-
related with expression data (e.g., to
determine if proximity of a gene to a peak
is correlated with its expression) or sub-
jected to a gene ontology analysis (e.g., to
Box 3. Peak calling: Punctate-source transcription factors
Nowadays, since ChIP-seq data of point-source factors are the most abundant
type, most peak callers are designed and fine-tuned for these factors. Existing
peak callers differ from each other in terms of signal smoothing and background
modeling. Because DNA around interaction sites is more easily sheared, the ends
of ChIPed DNA fragments would form footprints on DNA whose size is more
related to protein-DNA interaction than to size selection during library
preparation. Those peak callers able to capture this experiment-specific
information can greatly improve accuracy of prediction. For example, peak
callers SPP [9] and MACS [17] (version 2) use cross-correlation to find the lag
between reads mapped to the minus and the plus strand as the size of actual
protein-DNA interacting regions. After smoothing, background models are then
used to remove noise either directly from the control sample or from features of
the genome sequence such as GC content or mappability (BEADS [84]). Peaks are
finally called above a user-defined SNR level. Models used for the statistical
assessment of enriched regions (peaks) range from Poisson (CSAR [85]), local
Poisson (MACS), negative binomial (CisGenome [56]) to zero-inflated negative
binomial (ZINBA [86]), or even extend to more sophisticated machine learning
modeling techniques such as Hidden Markov Model (HPeak [87] and BayesPeak
[88]).
Most peak-calling algorithms apply a window-based method to detect peaks, so
nearby binding events may be erroneously merged. To improve the spatial
resolution of binding event predictions, several peak callers use peak shape as a
clue. PeakSplitter [89] can look for local maxima in a broader region containing
several sub-peaks. GPS [67] builds a probabilistic model of the distribution of
ChIP-seq reads at given peak candidate regions to deconvolve nearby homotypic
events. The R packages polyaPeak and NarrowPeaks can analyze the shape of the
peaks to re-rank and narrow down the final peak list, respectively. These
approaches are highly recommended as a post-processing step after general peak
calling for point-source factors.
Box 4. Peak calling: Broad enriched regions from histone marks
Due to the increasing interest in epigenetic regulation, epigenetic marks such as
histone modifications, DNA methylation, and chromatin remodeling factors are
being explored through ChIP-seq. Some of these marks are enriched strongly in
narrow genomic regions (e.g., H3K4me3 at gene promoters), and the peak callers
appropriate for point-source factors (discussed in Box 3) can be used. However,
most histone marks tend to have more broadly spreading and weaker patterns
(e.g., H3K27me3). Several peak callers are specifically designed for predicting
broad regions from ChIP-seq data, including SICER [90], CCAT [91], ZINBA, and
RSEG [92]. Other peak callers including SPP, MACS (version 2), and PeakRanger
[93] can also be used with this type of ChIP-seq data by using their options to
increase ‘‘bandwidth’’ or to relax the ‘‘peak cutoff.’’
For broad marks, the pattern of enrichment should be described as ‘‘domains’’
instead of ‘‘peaks’’ because there are no clearly defined peak summits. An
alternative representation of the pattern of mapped reads is hierarchical:
combining multiple levels of enrichment. For example, MACS (version 2) and
Scripture [94] (originally designed for RNA-seq) can make narrow calls for strong
enrichment inside broader calls for weak enrichment associated with domain
boundaries.
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determine if the ChIPed protein is in-
volved in particular biological processes).
Gene ontology analysis can be done using
DAVID [44], GREAT [45], or GSEA
[46]. Sometimes, the reads densities rela-
tive to a specific annotated feature are
plotted and compared across different
samples, thus revealing protein-binding
pattern differences between them [47].
Motif Analysis
Motif analysis is useful for much more
than just identifying the causal DNA-
binding motif in TF ChIP-seq peaks.
When the motif of the ChIPed protein is
already known, motif analysis provides
validation of the success of the experiment.
Even when the motif is not known before-
hand, identifying a centrally located motif
in a large fraction of the peaks by motif
analysis is indicative of a successful experi-
ment. Motif analysis can also identify the
DNA-binding motifs of other proteins that
bind in complex or in conjunction with the
ChIPed protein, illuminating the mecha-
nisms of transcriptional regulation. Motif
analysis is also useful with histone modi-
fication ChIP-seq because it can discover
unanticipated sequence signals associated
with such marks. Table S4 and [48,49]
list a small sample of the publicly available
tools for motif analysis.
Motif analysis is applied to the genomic
regions identified by peak-calling algorithms.
Hence, the first step in motif analysis is to
assemble a set of genomic sequences in
FASTA format corresponding to all the
significant ChIP-seq peaks [50–54]. The
second step in motif analysis is motif
discovery and it is advisable to input the
peak sequences to two or more of the many
algorithms able to discover sequence motifs
in unaligned DNA sequences [55–58], as
the algorithms have complementary strengths
and weaknesses. Some motif discovery
algorithms form part of pipelines that
perform several motif analysis steps (e.g.,
MEME-ChIP [57] and peak-motifs [58]),
including word-based motif discovery al-
gorithms and motif enrichment algorithms
that can identify motifs present in only a
small fraction of the peaks. Following motif
discovery, comparing the discovered motifs
with known DNA motifs using motif
comparison software [59,60] is useful to
confirm the presence of the ChIPed TF
motif if its (or its TF-family) binding motif is
known. The results will also provide hints
about other TFs that bind near the ChIPed
TF. Next, central motif enrichment anal-
ysis will determine if other known DNA
motifs are enriched near the centers (or
summits) of the ChIP-seq peaks [61]. It can
also be useful to perform local motif
enrichment analysis on regions centered
on genomic landmarks such as transcrip-
tion start sites overlapped by ChIP-seq
peaks [61]. Additionally, a motif spacing
analysis detects preferred distances and
arrangements of pairs of motifs that can be
indicative of physical interactions between
TFs [62]. Finally, motif prediction maps
and visualizes the genomic locations of the
motifs in each of the ChIP-seq regions
[63,64]. In this step, the discovered or
enriched motifs are used to scan the ChIP-
seq peak regions, and the coordinates of
the matches are uploaded to a genome
browser for visualization.
Outlook
The challenges of ChIP-seq require
novel experimental, statistical, and com-
putational solutions. Ongoing advances will
allow ChIP-seq to analyze samples con-
taining far fewer cells, greatly expanding its
applicability in areas such as embryology
and development where large samples are
prohibitively expensive or difficult to ob-
tain. Nano-ChIP-seq can analyze a sample
as small as 10,000 cells [65]. No less critical
is to trim today’s peaks that are much wider
than the actual transcription factor binding
sites. This is necessary to distinguish
artefacts from bona fide joint binding
events: most transcription factors competi-
tively, cooperatively, or co-bind with other
Box 5. Peak calling: Mixed signals
There are also some factors (such as RNA Pol II) that bind to DNA in regions with
bigger variation. It is known that some RNA Pol II complexes are stalled while
others are moving along with active transcription [95]. In the first case, data
ideally should be treated as for a point-source factor, whereas in the second case,
the data should be treated as for factors with broad marks. An ideal algorithm
should accommodate both patterns, which means peak calling should be more
general. Some tools have options for both narrow and broad peak calling, such as
SPP, MACS, ZINBA, and PeakRanger. However, with careful parameter tweaking
any algorithm suitable for broad peak detection would work for this type of data.
Box 6. Normalization
Whether comparing one ChIP sample against input DNA (sonicated DNA), ‘‘mock’’
ChIP (non-specific antibody, e.g., IgG) in peak calling, or comparing a ChIP sample
against another in differential analysis, there are linear and non-linear
normalization methods available to make the two samples ‘‘comparable’’ (Table
S2). Although many methodologies focus on normalization to a control sample,
none of them make the distinction on the type of control samples used. An
intuitive and commonly used linear normalization technique is called sequencing
depth normalization. In this method the number of reads is multiplied by a scale
factor to make the total reads in different samples the same (see [9,96] for details).
A slight modification of the method is used in PeakSeq [24], where a scale factor is
estimated in a region (,10 Kb) using linear regression. Many other existing
methods also use a normalization factor to linearly scale samples, focusing on
normalization against control samples (see for example CisGenome [56], MACS
[17], and USeq [97]). Another scaling normalization method known as RPKM
(Reads per Kilobase of sequence range per Million mapped reads) proposed in
[98] adjusts for biases due to the higher probability of reads falling into longer
regions.
A non-linear normalization adjusts for biases with non-linear trend. In a method
described in [28] the data is normalized with respect to mean and variance using
locally weighted regression (LOESS). It is based on the assumption that the effect
of biological condition change does not cause global binding alterations. This
assumption can be applied, for example, when comparing samples with different
stages of disease progression, or on samples before and after a certain treatment
(see section ‘‘Differential Binding Analysis’’). A modified version of this non-linear
normalization is implemented as MAnorm [34], assuming that peaks common in
the two conditions do not undergo global changes. The R package called
POLYPHEMUS [37] has also been developed, implementing two normalization
methods: (1) the non-linear method described in [28] and (2) a Quantile
normalization that makes the distribution in different samples the same.
Normalization issues are, at present, not fully exploited although they might
have a substantial impact on the results [28,37,99].
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transcription factors, the transcriptional
machinery, or cofactors. The effects of
context-dependent regulatory mechanisms
can fundamentally differ from the effects of
individual binding events [66]. To address
this issue, the Genome Positioning System
(GPS) resolves closely spaced peaks using a
segmented expectation maximization algo-
rithm [67]. A promising experimental
method for localizing narrow peaks is
ChIP-exo that uses bacteriophage l exo-
nuclease to digest the ends of DNA frag-
ments not bound to protein [68].
The number of false positive peaks can
be reduced both experimentally and
computationally. Improving antibody
specificity is a long-term endeavor, and
despite impressive progress, still a quarter
of histone modification antibodies fail the
specificity test [69]. Another way to
eliminate massive amounts of false positive
peaks is to limit the regulatory binding sites
to nucleosome-depleted regions, which are
accessible for regulator binding. These
regions are mapped by DNase I hypersen-
sitivity sequencing (DNase-seq) and similar
techniques: Thurman et al. found that 94%
of the human transcription factor binding
sites fell into DNase hypersensitivity regions
with only a few exceptions like the trans-
cription factors ZNF274, KAP1, and
SETDB1, which also bind to closed
chromatin [70]. False positive peaks are
also due to unrealistic p-values (and hence
FDRs) coming from unrealistic statistical
models used in most methods [71]. The
computational analysis of peak calling is
still in its infancy, expanding the diverse
and condition-specific performance of the
methods [72,73], therefore we recommend
using several methods for peak calling.
Perhaps the most important novel
developments are related to the detection
and analyses of distal regulatory regions,
which are distant in sequence but brought
close in 3-D space by DNA bending. To
reveal such 3-D mechanisms of transcrip-
tional regulation, two major techniques
have emerged: chromatin interaction anal-
ysis by paired-end tags (CHIA-PET) [74]
and chromosome conformation capture
assays such as circular chromosome con-
formation capture (4C) [75] or chromo-
some conformation capture carbon copy
(5C) [76].
Biological functions of binding sites are
not necessarily indicated by the reproduc-
ibility of peaks or FDR/IDR values (Box
8, [7,23,77,78]). This issue re-emerged
during the ENCODE Project that pro-
duced unprecedented regulatory infor-
mation [66,79] under rigorous quality
standards [7]. DNA-protein binding is
dynamic, and the measured strength of a
binding event depends (among other
things) on the fraction of cells in the (often
inhomogeneous) sample where it occurs,
as well as the proportion of the time it is
occupied in a given cell. Hence, ‘‘weak’’
binding sites, regardless of what signifi-
cance threshold is used, may have strong
biological functions [80–82]. ChIP-seq will
also detect indirect DNA binding by the
protein (via another protein or complex),
so predicted sites not containing the motif
may also be functional. Finally, binding
does not necessarily imply function, so it
will remain necessary to use additional
information (such as expression or chro-
matin conformation data) to reliably infer
the function of individual binding events
[83].
The diverse experimental and computa-
tional methods discussed here are revolu-
tionizing our understanding of the complex
networks that, by regulating transcription,
impact translation and almost all biological
processes.
Supporting Information
Text S1 Standard graphing track
data formats for genome browser
visualization.
(DOCX)
Figure S1 Assessment of read qual-
ity using strand cross-correlation.
Strand cross-correlation is computed as
the Pearson correlation between the pos-
itive and the negative strand profiles at
different strand shift distances, k. The
cross-correlation (panel A) usually peaks
at two distances of shift, one correspond-
ing to the read length, and one to the
average fragment length of the library.
The absolute and relative height of the two
peaks is useful for assessing IP enrichment.
Adapted from Landt et al. [7].
(TIF)
Figure S2 The irreproducible dis-
covery rate (IDR) framework for
Box 7. Duplicated reads
Duplicate (identical) reads present a challenge because they can arise from
independent DNA fragments or by PCR amplification of a single fragment. In the
former case, the duplicate reads are signals, in the latter case they are noise
(experimental artefact). A safe solution is to keep a fixed number of hits per
genomic location (considering different strands as different locations) according
to sequencing depth, and in this way better specificity (fewer false positive peaks)
can be achieved [8]. However in terms of estimating the protein’s affinity for a
given genomic region, it is more reasonable to consider all hits. This can be done
in a well-designed pipeline with certain steps before and after peak calling. For
example, one can remove a certain number of duplicates to call confident peaks,
and then put duplicates back to refine properties of these peaks such as peak
height and boundaries.
Box 8. Irreproducible discovery rate (IDR)
Given a set of peak calls for a pair of replicate data sets, the peaks can be ranked
based on a criterion of significance, such as the p-value, the q-value, or the fold
enrichment. Significant peaks generally are ranked more consistently across the
replicates than the peaks with low significance. This provides an indicator of the
transition from real signal to noise. IDR [23] quantifies this transition by classifying
peaks into a reproducible and an irreproducible group, where the peaks in the
reproducible group should be ranked higher and more consistently across
replicates than the irreproducible group (Figure S2). It assigns each signal a
reproducibility index, which estimates its probability to be reproducible, and also
reports the expected rate of irreproducible discoveries in the selected peaks
(referred to as IDR) in a fashion analogous to that of false discovery rate (FDR). An
R package for computing IDR is given in [23]. Prototypical examples illustrated
using ENCODE data may be found in [7]. When using IDR, a relatively relaxed
peak-calling threshold is advised because the IDR algorithm requires sampling of
both signal and noise distributions to assess the reproducibility of peaks.
A major advantage of the IDR method is that it is independent of the peak-calling
algorithms and can be applied to a variety of significance criteria, across labs and
platforms. It has been shown that it produces a stable threshold that is more
consistent across laboratories, antibodies, and analysis protocols (e.g., peak
callers) than FDR measures [7].
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assessing reproducibility of ChIP-seq
data sets. Panel A shows a scatterplot of
the significance scores of peaks identified
in two replicate ChIP-seq experiments.
The IDR method classifies peaks into
reproducible (black) and irreproducible
(red) groups, and computes for each peak
the probability that the peak belongs to the
irreproducible group. It ranks and selects
peaks according to this probability, and
computes IDR, the expected rate of
irreproducible discoveries in the selected
peaks. Panel B shows the estimated IDR at
different rank thresholds when the peaks
are sorted by the original significance
score.
(TIF)
Table S1 Examples of peak call-
ers employed in ChIP-seq. The list
includes tools that allow the processing
and post-processing of diverse types of
narrow read-enriched regions (peaks),
broad enriched regions (domains), and
mixed signals such as in RNA Pol II
ChIP-seq.
(DOCX)
Table S2 Normalization methods
for the comparative analysis of
ChIP-seq data sets.
(DOCX)
Table S3 Software packages for the
analysis of differential binding in
ChIP-seq. The table shows examples of
algorithms available for differential bind-
ing analysis using ChIP-seq data.
(DOCX)
Table S4 Software tools for motif
analysis of ChIP-seq peaks and
their uses. The table gives examples of
publicly available software tools for per-
forming motif analysis on ChIP-seq peaks
or nearby genes. The tools are grouped by
the major task (‘‘category’’), and check-
marks indicate the specific steps that each
tool performs. Web-based motif discovery
input size limits—ChIPMunk: unknown;
CompleteMOTIFS: 500,000 base pairs;
MEME-ChIP: 50,000,000 base pairs;
peak-motifs: no limit; Cistrome: 5,000 peaks.
(DOCX)
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